PCI Biotech Holding ASA Net Asset Quality Index
PCI Biotech Holding ASA net asset quality index. PCI Biotech Holding ASA (PCIB) has a Net Asset Quality Index of 67.6% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Nkr18.52 Million minus total liabilities of Nkr6.01 Million yields net assets of Nkr12.52 Million. A higher index indicates a stronger, lower-leverage balance sheet. See what is PCI Biotech Holding ASA's book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of PCI Biotech Holding ASA (2008–2024)
Net asset quality index of PCI Biotech Holding ASA from 2008 to 2024. This chart shows how PCI Biotech Holding ASA's Net Asset Quality Index has evolved across 17 annual periods from 2008 to 2024. As of June 2025, the index stands at 67.6%, representing net assets of Nkr12.52 Million against total assets of Nkr18.52 Million NOK. Check strategic asset allocation of PCI Biotech Holding ASA to assess the company's strategic physical and investment asset allocation.
PCI Biotech Holding ASA Net Asset Quality Index by Year (2008–2024)
PCI Biotech Holding ASA net asset quality index by year from 2008 to 2024. The table below presents the year-by-year Net Asset Quality Index for PCI Biotech Holding ASA from 2008 to 2024, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of PCI Biotech Holding ASA.
| Year | Quality Index | Net Assets (NOK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 75.1% | Nkr23.45 Million | Nkr31.21 Million | Nkr7.76 Million | ▼ -13.5 pp |
| 2023 | 88.6% | Nkr39.04 Million | Nkr44.05 Million | Nkr5.01 Million | ▼ -1.8 pp |
| 2022 | 90.4% | Nkr57.40 Million | Nkr63.48 Million | Nkr6.08 Million | ▲ +6.7 pp |
| 2021 | 83.7% | Nkr113.79 Million | Nkr135.98 Million | Nkr22.19 Million | ▼ -6.8 pp |
| 2020 | 90.5% | Nkr189.24 Million | Nkr209.12 Million | Nkr19.88 Million | ▲ +0.1 pp |
| 2019 | 90.4% | Nkr254.83 Million | Nkr282.03 Million | Nkr27.20 Million | ▼ -4.9 pp |
| 2018 | 95.2% | Nkr339.95 Million | Nkr357.06 Million | Nkr17.10 Million | ▲ +23.6 pp |
| 2017 | 71.6% | Nkr41.84 Million | Nkr58.44 Million | Nkr16.59 Million | ▲ +13.2 pp |
| 2016 | 58.4% | Nkr13.09 Million | Nkr22.40 Million | Nkr9.31 Million | ▼ -20.1 pp |
| 2015 | 78.5% | Nkr44.28 Million | Nkr56.40 Million | Nkr12.12 Million | ▲ +33.8 pp |
| 2014 | 44.7% | Nkr9.11 Million | Nkr20.38 Million | Nkr11.27 Million | ▼ -37.6 pp |
| 2013 | 82.3% | Nkr43.40 Million | Nkr52.74 Million | Nkr9.34 Million | ▼ -6.8 pp |
| 2012 | 89.1% | Nkr69.71 Million | Nkr78.20 Million | Nkr8.49 Million | ▼ -3.2 pp |
| 2011 | 92.4% | Nkr92.53 Million | Nkr100.17 Million | Nkr7.63 Million | ▲ +0.3 pp |
| 2010 | 92.0% | Nkr105.42 Million | Nkr114.54 Million | Nkr9.12 Million | ▲ +7.6 pp |
| 2009 | 84.5% | Nkr35.08 Million | Nkr41.53 Million | Nkr6.45 Million | ▼ -5.9 pp |
| 2008 | 90.3% | Nkr49.30 Million | Nkr54.58 Million | Nkr5.28 Million | — |